Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
Sponsor
University of Regensburg (Other)
Overall Status
Unknown status
CT.gov ID
NCT01292278
Collaborator
Technische Universität München (Other)
90
1
131
0.7
Study Details
Study Description
Brief Summary
Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Evaluation of Neuropeptides in CSF and serum in SAH patients
Study Design
Study Type:
Observational
Anticipated Enrollment
:
90 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage
Study Start Date
:
Jan 1, 2006
Anticipated Primary Completion Date
:
Aug 1, 2015
Anticipated Study Completion Date
:
Dec 1, 2016
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
aSAH consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage |
|
control group no neurological disease but spinal anesthesia |
Outcome Measures
Primary Outcome Measures
- Glasgow Outcome Scale [2011-2016]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- spontaneous or aneurysmal subarachnoid hemorrhage
Exclusion Criteria:
-
age younger than 18 years or older than 70 years
-
inflammatory disease
-
history of former SAH
-
no ventricular drainage
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Neurosurgery Medical Center University of Regensburg | Regensburg | Germany | 93053 |
Sponsors and Collaborators
- University of Regensburg
- Technische Universität München
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Karl-Michael Schebesch,
Karl-Michael Schebesch, MD,
University of Regensburg
ClinicalTrials.gov Identifier:
NCT01292278
Other Study ID Numbers:
- CSF 06/179
First Posted:
Feb 9, 2011
Last Update Posted:
Dec 5, 2014
Last Verified:
Dec 1, 2014
Keywords provided by Karl-Michael Schebesch,
Karl-Michael Schebesch, MD,
University of Regensburg
Additional relevant MeSH terms: